Eddit

(Unterschied zwischen Versionen)
Wechseln zu: Navigation, Suche
Zeile 6: Zeile 6:
 
{{tp|p=32257173|t=ä. An evidence-based framework for priority clinical research questions for COVID-19 |pdf=|usr=}}
 
{{tp|p=32257173|t=ä. An evidence-based framework for priority clinical research questions for COVID-19 |pdf=|usr=}}
 
{{tp|p=32133578|t=2020. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
 
{{tp|p=32133578|t=2020. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
 +
{{tp|p=32315723|t=ä. The epidemiological and clinical features of COVID-19 and lessons from this global infectious public health event |pdf=|usr=}}
 +
{{tp|p=32109444|t=2020. Coronavirus 2019-nCoV: A brief perspective from the front line |pdf=|usr=}} ''w structure of virus''
 +
  
 
*'''[[Clinical guidelines and advice]]'''
 
*'''[[Clinical guidelines and advice]]'''
Zeile 26: Zeile 29:
 
{{tp|p=32274964|t=2020. A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin |pdf=|usr=}}
 
{{tp|p=32274964|t=2020. A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin |pdf=|usr=}}
 
{{ttp|p=32169481|t=2020. COVID-19 spike-host cell receptor GRP78 binding site prediction |pdf=|usr=}}
 
{{ttp|p=32169481|t=2020. COVID-19 spike-host cell receptor GRP78 binding site prediction |pdf=|usr=}}
 +
{{tp|p=32092392|t=2020. Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV |pdf=|usr=}}
 +
 +
  
 
*'''[[Cytopathic effects]]'''
 
*'''[[Cytopathic effects]]'''
Zeile 34: Zeile 40:
  
 
*'''[[Immunology]]'''
 
*'''[[Immunology]]'''
 +
{{tp|p=32277967|t=ä. SAA is a biomarker to distinguish the severity and prognosis of Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
 +
{{tp|p=32325129|t=ä. The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia |pdf=|usr=}}
 +
{{tp|p=32315725|t=ä. Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China |pdf=|usr=}}
 +
{{tp|p=32283159|t=ä. Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19 |pdf=|usr=}}
 +
{{tp|p=32283164|t=ä. Clinical and laboratory-derived parameters of 119 hospitalized patients with coronavirus disease 2019 in Xiangyang, Hubei Province, China |pdf=|usr=}}
 +
{{tp|p=32283162|t=ä. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19 |pdf=|usr=}}
 +
{{tp|p=32358956|t=ä. Longitudinal Change of SARS-Cov2 Antibodies in Patients with COVID-19 |pdf=|usr=}}
 +
 +
{{tp|p=32227123|t=ä. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia |pdf=|usr=}}
  
  
Zeile 77: Zeile 92:
  
 
*'''[[Pathobiology]]'''
 
*'''[[Pathobiology]]'''
 
+
{{tp|p=32283163|t=ä. A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2 |pdf=|usr=}}
 
+
{{tp|p=32348495|t=ä. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with disease severity in COVID-19 |pdf=|usr=}}
  
 
*'''[[Disease Models]]'''
 
*'''[[Disease Models]]'''
Zeile 88: Zeile 103:
 
*'''[[Diagnosis (Laboratory)]]'''
 
*'''[[Diagnosis (Laboratory)]]'''
 
{{tp|p=32209385|t=ä. Profile of specific antibodies to SARS-CoV-2: The first report |pdf=|usr=}}
 
{{tp|p=32209385|t=ä. Profile of specific antibodies to SARS-CoV-2: The first report |pdf=|usr=}}
 
+
{{tp|p=32360885|t=ä. Value and Challenges: Nucleic Acid Amplification Tests for SARS?CoV-2 in Hospitalized COVID-19 Patients |pdf=|usr=}}
 +
{{tp|p=32335175|t=ä. Reliability and usefulness of a rapid IgM?IgG antibody test for the diagnosis of  SARS-CoV-2 infection: a preliminary report |pdf=|usr=}}
 +
{{tp|p=32335168|t=ä. Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients |pdf=|usr=}}
 +
{{tp|p=32298676|t=ä. Saliva is a reliable tool to detect SARS-CoV-2 |pdf=|usr=}}
  
 
*'''[[Diagnosis (Lung CT, Sonography)]]'''
 
*'''[[Diagnosis (Lung CT, Sonography)]]'''
Zeile 98: Zeile 116:
 
{{tp|p=32201155|t=ä. The evolution of CT characteristics in the patients with COVID-19 pneumonia |pdf=|usr=}}
 
{{tp|p=32201155|t=ä. The evolution of CT characteristics in the patients with COVID-19 pneumonia |pdf=|usr=}}
 
{{tp|p=32277968|t=ä. Clinical and CT imaging features of 2019 novel coronavirus disease (COVID-19) |pdf=|usr=}}
 
{{tp|p=32277968|t=ä. Clinical and CT imaging features of 2019 novel coronavirus disease (COVID-19) |pdf=|usr=}}
 +
{{tp|p=32275925|t=ä. Clinical and Imaging features of COVID-19 Patients: Analysis of Data from High-Altitude Areas |pdf=|usr=}}
 +
{{tp|p=C7152865|t=ä. CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China |pdf=|usr=}}
 +
{{tp|p=32112884|t=2020. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China |pdf=|usr=}}
 +
{{tp|p=32109443|t=ä. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2 |pdf=|usr=}}
 +
 +
  
  
Zeile 107: Zeile 131:
 
{{tp|p=32339975|t=2020. Safe bronchodilator treatment in mechanically ventilated COVID-19 patients: A single center experience |pdf=|usr=}}
 
{{tp|p=32339975|t=2020. Safe bronchodilator treatment in mechanically ventilated COVID-19 patients: A single center experience |pdf=|usr=}}
 
{{tp|p=32279018|t=ä. Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports |pdf=|usr=}}
 
{{tp|p=32279018|t=ä. Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports |pdf=|usr=}}
 
+
{{tp|p=32317225|t=ä. A sporadic COVID-19 pneumonia treated with extracorporeal membrane oxygenation in Tokyo, Japan: A case report |pdf=|usr=}}
  
  
Zeile 123: Zeile 147:
 
{{tp|p=32240670|t=2020. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up |pdf=|usr=}}
 
{{tp|p=32240670|t=2020. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up |pdf=|usr=}}
 
{{tp|p=32171866|t=ä. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients |pdf=|usr=}}
 
{{tp|p=32171866|t=ä. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients |pdf=|usr=}}
 +
{{tp|p=32335173|t=ä. How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review |pdf=|usr=}}
 +
{{tp|p=32335169|t=ä. Risk factors of critical & mortal COVID-19 cases: A systematic literature review  and meta-analysis |pdf=|usr=}}
 +
{{tp|p=32305490|t=ä. Risk Factors Associated with Disease Severity and Length of Hospital Stay in COVID-19 Patients |pdf=|usr=}}
 +
{{tp|p=32305487|t=ä. Risk factors for severe COVID-19: evidence from 167 hospitalized patients in Anhui, China |pdf=|usr=}}
 +
{{tp|p=32294503|t=ä. Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019 |pdf=|usr=}}
 +
{{tp|p=32283158|t=ä. Arterial hypertension and risk of death in patients with COVID-19 infection: systematic review and meta-analysis |pdf=|usr=}}
 +
{{tp|p=32179908|t=ä. A 55-Day-Old Female Infant Infected With 2019 Novel Coronavirus Disease: Presenting With Pneumonia, Liver Injury, and Heart Damage |pdf=|usr=}}
 +
  
 
*'''[[The morbid survivor]]'''
 
*'''[[The morbid survivor]]'''
 
{{tp|p=32334770|t=2020. The Need to Include Assisted Living in Responding to the COVID-19 Pandemic |pdf=|usr=}}
 
{{tp|p=32334770|t=2020. The Need to Include Assisted Living in Responding to the COVID-19 Pandemic |pdf=|usr=}}
 
{{tp|p=32222763|t=ä. COVID-19 Through the Lens of Gerontology |pdf=|usr=}}
 
{{tp|p=32222763|t=ä. COVID-19 Through the Lens of Gerontology |pdf=|usr=}}
 +
{{tp|p=32305489|t=ä. Clinical characteristics of older patients: The experience of a geriatric short-stay unit dedicated to patients with COVID-19 in France |pdf=|usr=}}
 +
 +
  
  
Zeile 141: Zeile 176:
 
{{tp|p=32114054|t=2020. COVID-19 in medical personnel: observation from Thailand |pdf=|usr=}}
 
{{tp|p=32114054|t=2020. COVID-19 in medical personnel: observation from Thailand |pdf=|usr=}}
 
{{tp|p=32171869|t=2020. Clinical progression of patients with COVID-19 in Shanghai, China |pdf=|usr=}}
 
{{tp|p=32171869|t=2020. Clinical progression of patients with COVID-19 in Shanghai, China |pdf=|usr=}}
 +
{{tp|p=32272120|t=ä. Critical patients with coronavirus disease 2019: Risk factors and outcome nomogram |pdf=|usr=}}
 +
{{tp|p=32360500|t=ä. Clinical and Transmission Dynamics Characteristics of 406 Children with Coronavirus Disease 2019 in China: A Review |pdf=|usr=}}
 +
{{tp|p=32360498|t=2020. Clinical features of critically ill patients with confirmed COVID-19 |pdf=|usr=}}
 +
{{tp|p=32353384|t=ä. Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort |pdf=|usr=}}
 +
{{tp|p=32335174|t=ä. Clinical Features and Outcomes of Asymptomatic Cases of SARS-CoV-2 Infection |pdf=|usr=}}
 +
{{tp|p=32335171|t=ä. Clinical and epidemiological features of COVID-19 family clusters in Beijing, China |pdf=|usr=}}
 +
{{tp|p=32335170|t=ä. Characteristics of a family cluster of Severe Acute Respiratory Syndrome Coronavirus 2 in Henan, China |pdf=|usr=}}
 +
{{tp|p=32315724|t=ä. Viral dynamics of SARS-CoV-2 across a spectrum of disease severity in COVID-19 |pdf=|usr=}}
 +
{{tp|p=32179910|t=ä. Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China |pdf=|usr=}}
  
  
Zeile 162: Zeile 206:
 
{{tp|p=32300051|t=2020. Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement  on access to IL-6-targeting therapies for COVID-19 |pdf=|usr=}}
 
{{tp|p=32300051|t=2020. Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement  on access to IL-6-targeting therapies for COVID-19 |pdf=|usr=}}
 
{{tp|p=32171872|t=ä. Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study |pdf=|usr=}}
 
{{tp|p=32171872|t=ä. Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study |pdf=|usr=}}
 
+
{{tp|p=32333918|t=ä. Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact |pdf=|usr=}}
 
+
{{tp|p=32283153|t=ä. Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-1 |pdf=|usr=}}
 +
{{tp|p=32362440|t=ä. Therapeutic potential of ciclesonide inahalation for COVID-19 pneumonia: Report of three cases |pdf=|usr=}}
 +
{{tp|p=32232474|t=ä. Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure |pdf=|usr=}}
 +
{{tp|p=32348485|t=ä. Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in COVID-19  Patients |pdf=|usr=}}
 +
{{tp|p=32348489|t=ä. COVID-19: Is Everything Appropriate to Create an Effective Vaccine?|pdf=|usr=}}
  
 
----
 
----
Zeile 181: Zeile 229:
 
{{tp|p=32171867|t=2020. Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation |pdf=|usr=}}
 
{{tp|p=32171867|t=2020. Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation |pdf=|usr=}}
 
{{tp|p=32209381|t=ä. Comparisons of viral shedding time of SARS-CoV-2 of different samples in ICU and  non-ICU patients |pdf=|usr=}}
 
{{tp|p=32209381|t=ä. Comparisons of viral shedding time of SARS-CoV-2 of different samples in ICU and  non-ICU patients |pdf=|usr=}}
 +
{{tp|p=32335176|t=ä. Positive rectal swabs in young patients recovered from coronavirus disease 2019 (COVID-19) |pdf=|usr=}}
 +
{{tp|p=32289343|t=ä. Recurrent PCR positivity after hospital discharge of people with coronavirus disease 2019 (COVID-19) |pdf=|usr=}}
 +
{{tp|p=32283161|t=ä. Duration for carrying SARS-CoV-2 in COVID-19 patients |pdf=|usr=}}
  
  
Zeile 206: Zeile 257:
 
{{tp|p=32360355|t=ä. COVID-19-associated shortage of alcohol-based hand rubs, face masks, medical gloves and gowns ? proposal for a risk-adapted approach to ensure patient and healthcare worker safety |pdf=|usr=}}
 
{{tp|p=32360355|t=ä. COVID-19-associated shortage of alcohol-based hand rubs, face masks, medical gloves and gowns ? proposal for a risk-adapted approach to ensure patient and healthcare worker safety |pdf=|usr=}}
 
{{tp|p=32304726|t=ä. Innovative technologies for hand hygiene monitoring are urgently needed in the fight against COVID-19 |pdf=|usr=}}
 
{{tp|p=32304726|t=ä. Innovative technologies for hand hygiene monitoring are urgently needed in the fight against COVID-19 |pdf=|usr=}}
 
+
{{tp|p=32301491|t=ä. Airborne or droplet precautions for health workers treating COVID-19?|pdf=|usr=}}
  
  
Zeile 240: Zeile 291:
 
{{tp|p=C7152925|t=ä. Minimising intra-hospital transmission of COVID-19: the role of social distancing |pdf=|usr=}}
 
{{tp|p=C7152925|t=ä. Minimising intra-hospital transmission of COVID-19: the role of social distancing |pdf=|usr=}}
 
{{tp|p=32223581|t=ä. International Perspectives Concerning Donor Milk Banking During the SARS-CoV-2 (COVID-19) Pandemic |pdf=|usr=}}
 
{{tp|p=32223581|t=ä. International Perspectives Concerning Donor Milk Banking During the SARS-CoV-2 (COVID-19) Pandemic |pdf=|usr=}}
 +
{{tp|p=32360881|t=ä. Environmental Contamination of SARS-CoV-2 in Healthcare Premises |pdf=|usr=}}
 +
{{tp|p=32251688|t=ä. China empowers Internet hospital to fight against COVID-19 |pdf=|usr=}}
 +
{{tp|p=32335177|t=ä. The economics of infection prevention: why it is crucial to invest in hand hygiene and nurses during the novel coronavirus pandemic |pdf=|usr=}}
 +
{{tp|p=32298677|t=ä. Clinical characteristics and prognosis in cancer patients with COVID-19: A single center s retrospective study |pdf=|usr=}}
  
 +
{{tp|p=32283160|t=ä. Airborne precautions recommended in Wuhan, China for bedside fiberoptic bronchoscopy examination of patients with COVID-19 |pdf=|usr=}}
  
  
Zeile 303: Zeile 359:
 
{{tp|p=32092391|t=ä. Novel coronavirus (2019-nCoV) cases in Hong Kong and implications for further spread |pdf=|usr=}}
 
{{tp|p=32092391|t=ä. Novel coronavirus (2019-nCoV) cases in Hong Kong and implications for further spread |pdf=|usr=}}
 
{{tp|p=32277969|t=ä. The Role of Phylogenetic Analysis in Clarifying the Infection Source of a COVID-19 Patient |pdf=|usr=}}
 
{{tp|p=32277969|t=ä. The Role of Phylogenetic Analysis in Clarifying the Infection Source of a COVID-19 Patient |pdf=|usr=}}
 +
{{tp|p=32268181|t=ä. The role of close contacts tracking management in COVID-19 prevention: A cluster  investigation in Jiaxing, China |pdf=|usr=}}
 +
{{tp|p=32360879|t=ä. Unintended Consequence: Influenza plunges with public health response to COVID-19 in Singapore |pdf=|usr=}}
 +
{{tp|p=32360497|t=ä. The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France |pdf=|usr=}}
 +
{{tp|p=32335172|t=ä. Personal respirators for population level control of the COVID19 pandemic |pdf=|usr=}}
 +
{{tp|p=32335167|t=ä. The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2 |pdf=|usr=}}
 +
{{tp|p=32325130|t=ä. Bayesian phylodynamic inference on the temporal evolution and global transmission of SARS-CoV-2 |pdf=|usr=}}
 +
{{tp|p=32305488|t=ä. Flattening-the-curve associated with reduced COVID-19 case fatality rates- an ecological analysis of 65 countries |pdf=|usr=}}
 +
{{tp|p=32302605|t=ä. Global COVID-19 fatality analysis reveals Hubei-like countries potentially with severe outbreaks |pdf=|usr=}}
 +
{{tp|p=32283165|t=ä. A cluster of the Corona Virus Disease 2019 caused by incubation period transmission in Wuxi, China |pdf=|usr=}}
 +
{{tp|p=32235084|t=2020. Spatial-temporal distribution of COVID-19 in China and its prediction: A data-driven modeling analysis |pdf=|usr=}}
 +
{{tp|p=32088679|t=2020. 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness |pdf=|usr=}}
 +
{{tp|p=32146445|t=2020. Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China |pdf=|usr=}}
 +
{{tp|p=32379708|t=2020. Sustainable health promotion for the seniors during COVID-19 outbreak: a lesson from Tokyo |pdf=|usr=}}
 +
{{tp|p=32379707|t=2020. Examining the incubation period distributions of COVID-19 on Chinese patients with different travel histories |pdf=|usr=}}
 +
{{tp|p=32193550|t=ä. Public Health Measures to Slow Community Spread of Coronavirus Disease 2019 |pdf=|usr=}}
 +
{{tp|p=32067043|t=ä. A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period |pdf=|usr=}}
 +
{{tp|p=32339231|t=ä. Epidemiological characteristics and incubation period of 7,015 confirmed cases with Coronavirus Disease 2019 outside Hubei Province in China |pdf=|usr=}}
 +
{{tp|p=32319519|t=ä. Transmission potential of asymptomatic and paucisymptomatic SARS-CoV-2 infections: a three-family cluster study in China |pdf=|usr=}}
 +
{{tp|p=32318703|t=ä. Epidemiological and clinical characteristics of 26 asymptomatic SARS-CoV-2 carriers |pdf=|usr=}}
 +
 +
 +
  
  
Zeile 317: Zeile 395:
 
{{tp|p=32316647|t=2020. Using Social Media to Mine and Analyze Public Opinion Related to COVID-19 in China |pdf=|usr=}}
 
{{tp|p=32316647|t=2020. Using Social Media to Mine and Analyze Public Opinion Related to COVID-19 in China |pdf=|usr=}}
 
*[https://www.businessinsider.com/nearly-half-of-reopen-america-twitter-accounts-are-bots-report-2020-5?utmSource=twitter&utmContent=referral&utmTerm=topbar&referrer=twitter twitter botwar]
 
*[https://www.businessinsider.com/nearly-half-of-reopen-america-twitter-accounts-are-bots-report-2020-5?utmSource=twitter&utmContent=referral&utmTerm=topbar&referrer=twitter twitter botwar]
 +
*[https://www.frontpagemag.com/point/2020/05/obama-clinton-9th-circuit-judges-suspend-bill-daniel-greenfield/  judges declare the Bill of Rights is suspended until the Coronavirus is cured]
 +
*[http://freerepublic.com/focus/f-news/3848303/posts They want you divided, and focused on other enemies.]
  
  
Zeile 322: Zeile 402:
 
{{tp|p=32142979|t=2020. Li Wenliang, a face to the frontline healthcare worker  The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak |pdf=|usr=}}
 
{{tp|p=32142979|t=2020. Li Wenliang, a face to the frontline healthcare worker  The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak |pdf=|usr=}}
 
{{tp|p=32271208|t=ä. Survey of COVID-19 Disease Among Orthopaedic Surgeons in Wuhan, People?s Republic of China |pdf=|usr=}}
 
{{tp|p=32271208|t=ä. Survey of COVID-19 Disease Among Orthopaedic Surgeons in Wuhan, People?s Republic of China |pdf=|usr=}}
 
+
{{tp|p=32277966|t=ä. Characteristics of deaths amongst health workers in China during the outbreak of  COVID-19 infection |pdf=|usr=}}
  
 
*'''[[Lost civilization]]'''
 
*'''[[Lost civilization]]'''
Zeile 339: Zeile 419:
 
{{tp|p=32145214|t=2020. Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection |pdf=|usr=}}
 
{{tp|p=32145214|t=2020. Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection |pdf=|usr=}}
 
{{tp|p=32092388|t=2020. Chinese medical personnel against the 2019-nCoV |pdf=|usr=}}
 
{{tp|p=32092388|t=2020. Chinese medical personnel against the 2019-nCoV |pdf=|usr=}}
 +
{{tp|p=32235086|t=2020. As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation |pdf=|usr=}}
 +
{{tp|p=32235085|t=2020. The novel zoonotic COVID-19 pandemic: An expected global health concern |pdf=|usr=}}
 +
{{tp|p=32235083|t=2020. Global outbreak of COVID-19: a new challenge?|pdf=|usr=}}
  
 
*'''[[Research tools]]'''
 
*'''[[Research tools]]'''

Version vom 26. Mai 2020, 15:29 Uhr


32257173 ä. An evidence-based framework for priority clinical research questions for COVID-19
32133578 2020. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)
32315723 ä. The epidemiological and clinical features of COVID-19 and lessons from this global infectious public health event
32109444 2020. Coronavirus 2019-nCoV: A brief perspective from the front line w structure of virus



32353109 ä. COVID-19 Pandemic: Considerations for Safe Medication Use in Older Adults with Multimorbidity and Polypharmacy
32343984 ä. COVID-19: before stopping specific infection control measures, be sure to exclude the diagnosis
32201156 ä. Multiple parameters required for diagnosis of COVID-19 in clinical practice




32361692 2020. How the COVID-19 Overcomes the Battle? An Approach to Virus Structure
32306836 2020. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment
32145215 ä. Identification of the hyper-variable genomic hotspot for the novel coronavirus SARS-CoV-2



32344526 2020. COVID-19 and RAS: Unravelling an Unclear Relationship
32274964 2020. A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin

32169481 2020. COVID-19 spike-host cell receptor GRP78 binding site prediction


32092392 2020. Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV



32277967 ä. SAA is a biomarker to distinguish the severity and prognosis of Coronavirus Disease 2019 (COVID-19)
32325129 ä. The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia
32315725 ä. Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China
32283159 ä. Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19
32283164 ä. Clinical and laboratory-derived parameters of 119 hospitalized patients with coronavirus disease 2019 in Xiangyang, Hubei Province, China
32283162 ä. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19
32358956 ä. Longitudinal Change of SARS-Cov2 Antibodies in Patients with COVID-19


32227123 ä. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia






32311448 ä. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up


32209382 ä. The clinical characteristics of myocardial injury in severe and very severe patients with 2019 novel coronavirus disease



32363540 ä. Bowel Necrosis in the Setting of COVID-19
32298767 ä. COVID-19: Abnormal liver function tests





32283163 ä. A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2
32348495 ä. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with disease severity in COVID-19




32209385 ä. Profile of specific antibodies to SARS-CoV-2: The first report
32360885 ä. Value and Challenges: Nucleic Acid Amplification Tests for SARS?CoV-2 in Hospitalized COVID-19 Patients
32335175 ä. Reliability and usefulness of a rapid IgM?IgG antibody test for the diagnosis of SARS-CoV-2 infection: a preliminary report
32335168 ä. Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients
32298676 ä. Saliva is a reliable tool to detect SARS-CoV-2


32373325 ä. Combination of CT and RT-PCR in the screening or diagnosis of COVID-19
32147407 ä. Diagnosis of SARS-CoV-2 Infection based on CT scan vs RT-PCR: Reflecting on Experience from MERS-CoV
32171865 2020. Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children
32142928 ä. Clinical and CT imaging features of 2019 novel coronavirus disease (COVID-19)
32205140 ä. The progression of computed tomographic (CT) images in patients with coronavirus disease (COVID-19) pneumonia: Running title: The CT progression of COVID-19 pneumonia
32201155 ä. The evolution of CT characteristics in the patients with COVID-19 pneumonia
32277968 ä. Clinical and CT imaging features of 2019 novel coronavirus disease (COVID-19)
32275925 ä. Clinical and Imaging features of COVID-19 Patients: Analysis of Data from High-Altitude Areas
C7152865 ä. CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China
32112884 2020. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China
32109443 ä. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2




32344326 2020. COVID-19 and malaria: A symptom screening challenge for malaria endemic countries



32339975 2020. Safe bronchodilator treatment in mechanically ventilated COVID-19 patients: A single center experience
32279018 ä. Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports
32317225 ä. A sporadic COVID-19 pneumonia treated with extracorporeal membrane oxygenation in Tokyo, Japan: A case report




32300796 ä. A geroscience perspective on COVID-19 mortality
32279081 ä. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study
32360995 ä. No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease
32278005 ä. Non-alcoholic fatty liver diseases in patients with COVID-19: A etrospective study
32348791 ä. Clinical characteristics of COVID-19 patients with abnormal liver tests
32348790 ä. Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis
32305291 ä. Multicenter analysis of clinical characteristics and outcome of COVID-19 patients with liver injury
32145216 ä. Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy
32240670 2020. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up
32171866 ä. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients
32335173 ä. How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review
32335169 ä. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis
32305490 ä. Risk Factors Associated with Disease Severity and Length of Hospital Stay in COVID-19 Patients
32305487 ä. Risk factors for severe COVID-19: evidence from 167 hospitalized patients in Anhui, China
32294503 ä. Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019
32283158 ä. Arterial hypertension and risk of death in patients with COVID-19 infection: systematic review and meta-analysis
32179908 ä. A 55-Day-Old Female Infant Infected With 2019 Novel Coronavirus Disease: Presenting With Pneumonia, Liver Injury, and Heart Damage



32334770 2020. The Need to Include Assisted Living in Responding to the COVID-19 Pandemic
32222763 ä. COVID-19 Through the Lens of Gerontology
32305489 ä. Clinical characteristics of older patients: The experience of a geriatric short-stay unit dedicated to patients with COVID-19 in France




32269194 2020. Pneumonia Without Respiratory Symptoms
32361703 2020. Newly Diagnosed Glomerulonephritis During COVID-19 Infection Undergoing Immunosuppression Therapy, a Case Report
32113824 ä. First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan
32334915 ä. Letter to the Editor: Update on the followed-up CT exam of the first CoVID-19 pneumonia in Taiwan
32362920 2020. Armarium facilitating angina management post myocardial infarction concomitant with coronavirus disease 2019
32205138 ä. The index case of SARS-CoV-2 in Scotland


32302722 ä. Clinical characteristics of 80 hospitalized frontline medical workers infected with COVID-19 in Wuhan, China
32114054 2020. COVID-19 in medical personnel: observation from Thailand
32171869 2020. Clinical progression of patients with COVID-19 in Shanghai, China
32272120 ä. Critical patients with coronavirus disease 2019: Risk factors and outcome nomogram
32360500 ä. Clinical and Transmission Dynamics Characteristics of 406 Children with Coronavirus Disease 2019 in China: A Review
32360498 2020. Clinical features of critically ill patients with confirmed COVID-19
32353384 ä. Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort
32335174 ä. Clinical Features and Outcomes of Asymptomatic Cases of SARS-CoV-2 Infection
32335171 ä. Clinical and epidemiological features of COVID-19 family clusters in Beijing, China
32335170 ä. Characteristics of a family cluster of Severe Acute Respiratory Syndrome Coronavirus 2 in Henan, China
32315724 ä. Viral dynamics of SARS-CoV-2 across a spectrum of disease severity in COVID-19
32179910 ä. Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China



32305438 ä. The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19





32290293 2020. A Review of SARS-CoV-2 and the Ongoing Clinical Trials



32171450 2020. Identification of potential cross-protective epitope between a new type of coronavirus (2019-nCoV) and severe acute respiratory syndrome virus
32173287 ä. Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines
32373322 ä. Fighting COVID-19 with water dehydration of mucous glycans
32372051 ä. Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2
32335161 ä. In the search of potential epitopes for Wuhan seafood market pneumonia virus using high order nullomers
32300051 2020. Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
32171872 ä. Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
32333918 ä. Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
32283153 ä. Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-1
32362440 ä. Therapeutic potential of ciclesonide inahalation for COVID-19 pneumonia: Report of three cases
32232474 ä. Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure
32348485 ä. Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in COVID-19 Patients
32348489 ä. COVID-19: Is Everything Appropriate to Create an Effective Vaccine?






32200109 2020. SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern regarding the present standard for discharge
32251796 ä. The enlightenment from two cases of asymptomatic infection with SARS-CoV-2: is it safe after 14 days of isolation?
32147538 2020. Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report
32340768 ä. Risk of reactivation or reinfection of novel coronavirus (COVID-19)
32314129 ä. A Case Series of Recurrent Viral RNA Positivity in Recovered COVID-19 Chinese Patients
32171867 2020. Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation
32209381 ä. Comparisons of viral shedding time of SARS-CoV-2 of different samples in ICU and non-ICU patients
32335176 ä. Positive rectal swabs in young patients recovered from coronavirus disease 2019 (COVID-19)
32289343 ä. Recurrent PCR positivity after hospital discharge of people with coronavirus disease 2019 (COVID-19)
32283161 ä. Duration for carrying SARS-CoV-2 in COVID-19 patients



32335340 ä. Potential Fecal Transmission of SARS-CoV-2: Current Evidence and Implications for Public Health
32278800 ä. Sexual transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A new possible route of infection?
32329026 ä. Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab
32315667 ä. Put a lid on it: Are faecal bio-aerosols a route of transmission for SARS-CoV-2?
32145217 2020. Public health might be endangered by possible prolonged discharge of SARS-CoV-2 in stool



32340347 2020. Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough
32360356 ä. Putting some context to the aerosolization debate around SARS-CoV-2



32142885 2020. Association between 2019-nCoV transmission and N95 respirator use
32201338 ä. Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy
32035997 2020. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents
32277965 ä. Disinfection of N95 respirators by ionized hydrogen peroxide during pandemic coronavirus disease 2019 (COVID-19) due to SARS-CoV-2
32277964 ä. Sterilization of disposable face masks by means of standardized dry and steam sterilization processes; an alternative in the fight against mask shortages due to COVID-19
32348833 ä. What face mask for what use in the context of COVID-19 pandemic? The French guidelines
32360355 ä. COVID-19-associated shortage of alcohol-based hand rubs, face masks, medical gloves and gowns ? proposal for a risk-adapted approach to ensure patient and healthcare worker safety
32304726 ä. Innovative technologies for hand hygiene monitoring are urgently needed in the fight against COVID-19
32301491 ä. Airborne or droplet precautions for health workers treating COVID-19?



32347453 ä. Redesigning a Department of Surgery during the COVID-19 Pandemic
32314235 ä. Practical Implications of Novel Coronavirus COVID-19 on Hospital Operations, Board Certification, and Medical Education in Surgery in the USA
32285338 ä. What Is the Appropriate Use of Laparoscopy over Open Procedures in the Current COVID-19 Climate?
32340908 ä. Perspectives from the Cancer and Aging Research Group: Caring for the vulnerable older patient with cancer and their caregivers during the COVID-19 crisis in the United States
32273247 ä. Challenges with the management of older patients with cancer during the COVID-19 pandemic
32331928 ä. Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma
32327321 ä. Development of a telehealth geriatric assessment model in response to the COVID-19 pandemic
32246144 ä. The Impact of the COVID-19 Pandemic on Disabled and Hospice Home Care Patients
32314784 ä. A Frail Health Care System for an Old Population: Lesson form the COVID-19 Outbreak in Italy
32353526 ä. Continues Renal Replacement Therapy (CRRT) With Disposable Hemoperfusion Cartridge: A Promising Option for Severe COVID-19
32373323 ä. Saving the frontline health workforce amidst the COVID-19 crisis: Challenges and recommendations
32298769 ä. The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care
32169615 ä. Makeshift hospitals for COVID-19 patients: where health-care workers and patients need sufficient ventilation for more protection
32283134 ä. Highlights for management of patients with Autoimmune Liver Disease during COVID-19 pandemia
32142887 ä. Practical experiences and suggestions for the ?eagle-eyed observer?: a novel promising role for controlling nosocomial infection in the COVID-19 outbreak
32142886 ä. Effective strategies to prevent coronavirus disease-2019 (COVID-19) outbreak in hospital
32243949 ä. Ark of Life and Hope: the role of the Cabin Hospital in facing COVID-19
32205162 ä. Rapid response to COVID-19 outbreak in Northern Italy: how to convert a classic infectious disease ward into a COVID-19 response centre
32205161 ä. Strategies for qualified triage stations and fever clinics during the outbreak of COVID-2019 in the county hospitals of Western Chongqing
32278704 ä. Body Temperature Measurement to Prevent Pandemic COVID-19 in Hospitals in Taiwan: Repeated Measurement is Necessary
32151674 ä. Duration of quarantine in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a question needing an answer
32259547 ä. COVID-19 contagion and contamination through hands of trauma patients: what risks and what precautions?
32360337 ä. Factors Associated with Preventive Behaviours of COVID-19 among Hospital Staff in Iran in 2020: An Application of the Protection Motivation Theory
32339619 ä. Infection prevention partners up with psychology in a Danish Hospital successfully addressing staffs fear during the COVID-19 pandemic
32339615 2020. COVID-19: how prepared are front-line healthcare workers in England?
32304725 ä. Environmental virus surveillance in the isolation ward of COVID-19
32302723 ä. Preparedness for COVID-19 infection prevention in Korea: Single-center experience
C7152925 ä. Minimising intra-hospital transmission of COVID-19: the role of social distancing
32223581 ä. International Perspectives Concerning Donor Milk Banking During the SARS-CoV-2 (COVID-19) Pandemic
32360881 ä. Environmental Contamination of SARS-CoV-2 in Healthcare Premises
32251688 ä. China empowers Internet hospital to fight against COVID-19
32335177 ä. The economics of infection prevention: why it is crucial to invest in hand hygiene and nurses during the novel coronavirus pandemic
32298677 ä. Clinical characteristics and prognosis in cancer patients with COVID-19: A single center s retrospective study


32283160 ä. Airborne precautions recommended in Wuhan, China for bedside fiberoptic bronchoscopy examination of patients with COVID-19





32259628 ä. Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist
32208139 ä. Coronavirus Disease 2019 (COVID-19) and Beyond: Micropractices for Burnout Prevention and Emotional Wellness



32307522 ä. Assessing the Impact of the COVID-19 Pandemic and Accompanying Mitigation Efforts on Older Adults
32296840 ä. Aging in Times of the COVID-19 Pandemic: Avoiding Ageism and Fostering Intergenerational Solidarity
32282920 ä. ?We?re staying at home? Association of self-perceptions of aging, personal and family resources and loneliness with psychological distress during the lock-down period of COVID-19
32355556 ä. Impact of coronavirus outbreak on psychological health


32283124 ä. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic



32147406 ä. Reasons for healthcare workers becoming infected with novel coronavirus disease 2019 (COVID-19) in China
32243947 ä. Beyond the assistance: additional exposure situations to COVID-19 for healthcare workers
32278703 ä. Preventing the Transmission of COVID-19 Amongst Healthcare Workers
32278701 ä. Knowledge, attitude and practice regarding COVID-19 among health care workers in Henan, China


32325710 2020. The COVID-19 Outbreak and Affected Countries Stock Markets Response
32305533 ä. The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review
32292707 ä. Death and contagious infectious diseases: Impact of the COVID-19 virus on stock market returns






32277970 ä. Strategies to trace back the origin of COVID-19



32373340 ä. Epidemiological analysis of the early 38 fatalities in Hubei, China, of the coronavirus disease 2019
32373339 ä. More effective strategies are required to strengthen public awareness of COVID-19: Evidence from Google Trends
32373318 ä. The COVID-19 containment in Vietnam: What are we doing?
32257174 ä. When will the battle against novel coronavirus end in Wuhan: A SEIR modeling analysis
32277963 ä. Super-spreading events and contribution to transmission of MERS, SARS, and COVID-19
32259546 ä. Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong
32092368 2020. The non-contact handheld cutaneous infra-red thermometer for fever screening during the COVID-19 global emergency
32057788 2020. Novel coronavirus, poor quarantine, and the risk of pandemic
32119884 2020. Novel coronavirus disease (Covid-19): The first two patients in the UK with person to person transmission
32112887 2020. Simulating and forecasting the cumulative confirmed cases of SARS-CoV-2 in China by Boltzmann function-based regression analyses
32209384 ä. Wuhan and Hubei COVID-19 mortality analysis reveals the critical role of timely supply of medical resources
32209383 ä. Herd immunity ? estimating the level required to halt the COVID-19 epidemics in affected countries
32092391 ä. Novel coronavirus (2019-nCoV) cases in Hong Kong and implications for further spread
32277969 ä. The Role of Phylogenetic Analysis in Clarifying the Infection Source of a COVID-19 Patient
32268181 ä. The role of close contacts tracking management in COVID-19 prevention: A cluster investigation in Jiaxing, China
32360879 ä. Unintended Consequence: Influenza plunges with public health response to COVID-19 in Singapore
32360497 ä. The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France
32335172 ä. Personal respirators for population level control of the COVID19 pandemic
32335167 ä. The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2
32325130 ä. Bayesian phylodynamic inference on the temporal evolution and global transmission of SARS-CoV-2
32305488 ä. Flattening-the-curve associated with reduced COVID-19 case fatality rates- an ecological analysis of 65 countries
32302605 ä. Global COVID-19 fatality analysis reveals Hubei-like countries potentially with severe outbreaks
32283165 ä. A cluster of the Corona Virus Disease 2019 caused by incubation period transmission in Wuxi, China
32235084 2020. Spatial-temporal distribution of COVID-19 in China and its prediction: A data-driven modeling analysis
32088679 2020. 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness
32146445 2020. Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China
32379708 2020. Sustainable health promotion for the seniors during COVID-19 outbreak: a lesson from Tokyo
32379707 2020. Examining the incubation period distributions of COVID-19 on Chinese patients with different travel histories
32193550 ä. Public Health Measures to Slow Community Spread of Coronavirus Disease 2019
32067043 ä. A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period
32339231 ä. Epidemiological characteristics and incubation period of 7,015 confirmed cases with Coronavirus Disease 2019 outside Hubei Province in China
32319519 ä. Transmission potential of asymptomatic and paucisymptomatic SARS-CoV-2 infections: a three-family cluster study in China
32318703 ä. Epidemiological and clinical characteristics of 26 asymptomatic SARS-CoV-2 carriers





32373315 ä. The need to improve the laws and regulations relevant to the outbreak of COVID-19: What might be learned from China?





32316647 2020. Using Social Media to Mine and Analyze Public Opinion Related to COVID-19 in China



32142979 2020. Li Wenliang, a face to the frontline healthcare worker The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak
32271208 ä. Survey of COVID-19 Disease Among Orthopaedic Surgeons in Wuhan, People?s Republic of China
32277966 ä. Characteristics of deaths amongst health workers in China during the outbreak of COVID-19 infection




32120913 2020. Epidemiological Identification of A Novel Pathogen in Real Time: Analysis of the Atypical Pneumonia Outbreak in Wuhan, China, 2019?2020
32001309 2020. Emergence of a novel coronavirus causing respiratory illness from Wuhan, China



32315025 ä. After the COVID-19 Pandemic: The Next Wave of Health Challenges for Older Adults
32156648 ä. 2019-novel coronavirus outbreak: A new challenge
32355555 ä. COVID-19 must catalyse key global natural experiments
32145214 2020. Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection
32092388 2020. Chinese medical personnel against the 2019-nCoV
32235086 2020. As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation
32235085 2020. The novel zoonotic COVID-19 pandemic: An expected global health concern
32235083 2020. Global outbreak of COVID-19: a new challenge?

  • from the ads
  • [lifechemicals.com antiviral candidate drugs]
  • [biomol.com assays cytokines general spectrum]
  • [labospace.com custom single probe assay 400 possible cytokines and so on]
  • [codexdna.com dna synthesis]
Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis